Genomic Recombination of SARS-CoV-2 Subvariants BA.5.2.48 and BF.7.14 - China, 2023

China CDC Wkly. 2023 Apr 7;5(14):318-320. doi: 10.46234/ccdcw2023.058.

Zhongxian Zhang¹, Han Li², Hongxia Ma³, Wenling Wang¹, Dawei Gao⁴, Fei Ye¹, Weibang Huo¹, Yuda Chen^{1

2}, Changcheng Wu¹, Wenjie Tan^{1

2}

¹ National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
² School of Public Health, Baotou Medical College, Baotou City, Inner Mongolia Autonomous Region, China.
³ Henan Provincial Center for Disease Control and Prevention, Zhengzhou City, Henan Province, China.
⁴ Lu'an Municipal Center for Disease Control and Prevention, Lu'an City, Anhui Province, China.

No abstract available

Keywords: BA.5.2; BF.7.14; Genomic Recombination; SARS-CoV-2.

Grants and funding

Supported by National Key R&D Program of China (2022YFC230410, 2022 YFC2303401, 2021YFC2300101 and 2021YFA1201003)